165 related articles for article (PubMed ID: 12214255)
1. Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability.
Duensing S; Münger K
Oncogene; 2002 Sep; 21(40):6241-8. PubMed ID: 12214255
[TBL] [Abstract][Full Text] [Related]
2. Centrosome abnormalities and genomic instability induced by human papillomavirus oncoproteins.
Duensing S; Münger K
Prog Cell Cycle Res; 2003; 5():383-91. PubMed ID: 14593733
[TBL] [Abstract][Full Text] [Related]
3. Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins.
Duensing A; Spardy N; Chatterjee P; Zheng L; Parry J; Cuevas R; Korzeniewski N; Duensing S
Environ Mol Mutagen; 2009 Oct; 50(8):741-7. PubMed ID: 19326465
[TBL] [Abstract][Full Text] [Related]
4. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.
Duensing S; Münger K
Cancer Res; 2002 Dec; 62(23):7075-82. PubMed ID: 12460929
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype.
Duensing S; Duensing A; Crum CP; Münger K
Cancer Res; 2001 Mar; 61(6):2356-60. PubMed ID: 11289095
[TBL] [Abstract][Full Text] [Related]
6. Centrosomes, genomic instability, and cervical carcinogenesis.
Duensing S; Münger K
Crit Rev Eukaryot Gene Expr; 2003; 13(1):9-23. PubMed ID: 12839094
[TBL] [Abstract][Full Text] [Related]
7. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle.
Duensing S; Lee LY; Duensing A; Basile J; Piboonniyom S; Gonzalez S; Crum CP; Munger K
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10002-7. PubMed ID: 10944189
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase inhibitor indirubin-3'-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies.
Duensing S; Duensing A; Lee DC; Edwards KM; Piboonniyom SO; Manuel E; Skaltsounis L; Meijer L; Münger K
Oncogene; 2004 Oct; 23(50):8206-15. PubMed ID: 15378001
[TBL] [Abstract][Full Text] [Related]
9. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis.
Riley RR; Duensing S; Brake T; Münger K; Lambert PF; Arbeit JM
Cancer Res; 2003 Aug; 63(16):4862-71. PubMed ID: 12941807
[TBL] [Abstract][Full Text] [Related]
10. Notch1 can contribute to viral-induced transformation of primary human keratinocytes.
Lathion S; Schaper J; Beard P; Raj K
Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182
[TBL] [Abstract][Full Text] [Related]
11. RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts.
Iovino F; Lentini L; Amato A; Di Leonardo A
Mol Cancer; 2006 Sep; 5():38. PubMed ID: 16987420
[TBL] [Abstract][Full Text] [Related]
12. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.
Münger K; Basile JR; Duensing S; Eichten A; Gonzalez SL; Grace M; Zacny VL
Oncogene; 2001 Nov; 20(54):7888-98. PubMed ID: 11753671
[TBL] [Abstract][Full Text] [Related]
13. Genomic instability and cancer: lessons learned from human papillomaviruses.
Korzeniewski N; Spardy N; Duensing A; Duensing S
Cancer Lett; 2011 Jun; 305(2):113-22. PubMed ID: 21075512
[TBL] [Abstract][Full Text] [Related]
14. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation.
Fehrmann F; Laimins LA
Oncogene; 2003 Aug; 22(33):5201-7. PubMed ID: 12910257
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein.
Grm HS; Massimi P; Gammoh N; Banks L
Oncogene; 2005 Aug; 24(33):5149-64. PubMed ID: 15856010
[TBL] [Abstract][Full Text] [Related]
17. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
18. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
19. Analysis of centrosome overduplication in correlation to cell division errors in high-risk human papillomavirus (HPV)-associated anal neoplasms.
Duensing A; Chin A; Wang L; Kuan SF; Duensing S
Virology; 2008 Mar; 372(1):157-64. PubMed ID: 18036631
[TBL] [Abstract][Full Text] [Related]
20. HPV-mediated transformation of the anogenital tract.
Steenbergen RD; de Wilde J; Wilting SM; Brink AA; Snijders PJ; Meijer CJ
J Clin Virol; 2005 Mar; 32 Suppl 1():S25-33. PubMed ID: 15753009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
